As of 2025-07-15, the Fair Value of Oncolytics Biotech Inc (ONC.TO) is -2.29 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.60 CAD, the upside of Oncolytics Biotech Inc is -243.01%.
With the market price of 1.60 CAD and our fair value calculation, Oncolytics Biotech Inc (ONC.TO) is not a good investment. Investing in ONC.TO stocks now will result in a potential loss of 243.01%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -22.51 | -26.30 | -24.84 | -27.75 | -31.71 | -26.62 |
| YoY growth | 32.04% | -16.84% | 5.55% | -11.72% | -14.26% | -1.05% |
| Market Cap (mil) | 110.14 |
| P/E | |
| Forward P/E |
| EPS | -0.46 |
| Avg earnings growth rate | -1.05% |
| TTM earnings | -31.50 |